Get started
WEST PHARMACEUTICAWEST PHARMACEUTICAWEST PHARMACEUTICA

WEST PHARMACEUTICA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

WPS chart


Full chart

WPS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.28 B‬ CHF
Dividend yield (indicated)
0.40%
Price to earnings Ratio (TTM)
37.398
Basic EPS (TTM)
5.684 CHF
Net income (FY)
‪447.47 M‬ CHF
Revenue (FY)
‪2.63 B‬ CHF
Shares float
‪71.39 M‬
Beta (1Y)
0.54

Employees


Employees (FY)
‪10.6 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪247.84 K‬ CHF
Net income / Employee (1Y)
‪42.21 K‬ CHF

About West Pharmaceutical Services, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Eric Mark Green
Website
westpharma.com
Headquarters
Exton
Founded
1923
FIGI
BBG00LVGJRP6
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

WPS news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as WPS.

Frequently Asked Questions


The current price of WPS is 182.010 CHF — it has decreased by −8.09% in the past 24 hours. Watch WEST PHARMACEUTICA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange WEST PHARMACEUTICA stocks are traded under the ticker WPS.
WPS stock has fallen by −8.09% compared to the previous week, the month change is a −8.09% fall, over the last year WEST PHARMACEUTICA has showed a −47.20% decrease.
We've gathered analysts' opinions on WEST PHARMACEUTICA future price: according to them, WPS price has a max estimate of 268.69 CHF and a min estimate of 202.55 CHF. Watch WPS chart and read a more detailed WEST PHARMACEUTICA stock forecast: see what analysts think of WEST PHARMACEUTICA and suggest that you do with its stocks.
WPS reached its all-time high on Sep 23, 2021 with the price of 420.918 CHF, and its all-time low was 182.010 CHF and was reached on May 14, 2025. View more price dynamics on WPS chart.
See other stocks reaching their highest and lowest prices.
WPS stock is 8.80% volatile and has beta coefficient of 0.54. Track WEST PHARMACEUTICA stock price on the chart and check out the list of the most volatile stocks — is WEST PHARMACEUTICA there?
Today WEST PHARMACEUTICA has the market capitalization of ‪12.28 B‬, it has increased by 3.01% over the last week.
Yes, you can track WEST PHARMACEUTICA financials in yearly and quarterly reports right on TradingView.
WEST PHARMACEUTICA is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
WPS earnings for the last quarter are 1.28 CHF per share, whereas the estimation was 1.09 CHF resulting in a 18.13% surprise. The estimated earnings for the next quarter are 1.26 CHF per share. See more details about WEST PHARMACEUTICA earnings.
WEST PHARMACEUTICA revenue for the last quarter amounts to ‪617.90 M‬ CHF, despite the estimated figure of ‪607.00 M‬ CHF. In the next quarter, revenue is expected to reach ‪604.00 M‬ CHF.
WPS net income for the last quarter is ‪79.50 M‬ CHF, while the quarter before that showed ‪118.16 M‬ CHF of net income which accounts for −32.72% change. Track more WEST PHARMACEUTICA financial stats to get the full picture.
Yes, WPS dividends are paid quarterly. The last dividend per share was 0.17 CHF. As of today, Dividend Yield (TTM)% is 0.40%. Tracking WEST PHARMACEUTICA dividends might help you take more informed decisions.
WEST PHARMACEUTICA dividend yield was 0.25% in 2024, and payout ratio reached 12.27%. The year before the numbers were 0.22% and 9.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 25, 2025, the company has ‪10.6 K‬ employees. See our rating of the largest employees — is WEST PHARMACEUTICA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WEST PHARMACEUTICA EBITDA is ‪670.49 M‬ CHF, and current EBITDA margin is 25.93%. See more stats in WEST PHARMACEUTICA financial statements.
Like other stocks, WPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WEST PHARMACEUTICA stock right from TradingView charts — choose your broker and connect to your account.